Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

IRB

Showing results (701-710 of 778) with videos related to

Pageof 78
Sort By:
IRB|July 10, 2003
Consent for continuing research participation: what is it and when should it be obtained?Dave Wendler, Jonathan Rackoff
IRB|June 27, 2003
Studying benefit in gene transferG E Henderson, N M King
IRB|September 19, 2003
Barriers encountered conducting informed consent researchPatricia Agre, Bruce Rapkin, James Dougherty, et al.
IRB|September 19, 2003
Quality improvement or research: a distinction without a difference?David Doezema, Mark Hauswald
IRB|July 9, 2011
Off the beaten path: conducting ethical pragmatic trials with marginalized populationsDiego S Silva, Paula N Goering, Nora Jacobson, et al.
IRB|July 9, 2011
Parents' understanding and recall of informed consent information for neonatal researchHubert Otho Ballard, Lori Ann Shook, Joseph Iocono, et al.
IRB|September 5, 2008
How should we communicate the likelihood of risks to inform decisions about consent?Thomas S Rector
IRB|February 15, 2011
Unrealistic optimism in early-phase oncology trialsLynn A Jansen, Paul S Appelbaum, William M P Klein, et al.
IRB|February 15, 2011
Consent for future genetic research: the NHANES experience in 2007-2008Geraldine M McQuillan, Kathryn S Porter
IRB|July 2, 2010
The process is the product: a new model for multisite IRB review of data-only studiesSarah M Greene, Jeffrey Braff, Andrew Nelson, et al.
Pageof 78

Showing results (701-710 of 778) with videos related to

Sort By:
Pageof 78
IRB|July 10, 2003
Consent for continuing research participation: what is it and when should it be obtained?Dave Wendler, Jonathan Rackoff
IRB|June 27, 2003
Studying benefit in gene transferG E Henderson, N M King
IRB|September 19, 2003
Barriers encountered conducting informed consent researchPatricia Agre, Bruce Rapkin, James Dougherty, et al.
IRB|September 19, 2003
Quality improvement or research: a distinction without a difference?David Doezema, Mark Hauswald
IRB|July 9, 2011
Off the beaten path: conducting ethical pragmatic trials with marginalized populationsDiego S Silva, Paula N Goering, Nora Jacobson, et al.
IRB|July 9, 2011
Parents' understanding and recall of informed consent information for neonatal researchHubert Otho Ballard, Lori Ann Shook, Joseph Iocono, et al.
IRB|September 5, 2008
How should we communicate the likelihood of risks to inform decisions about consent?Thomas S Rector
IRB|February 15, 2011
Unrealistic optimism in early-phase oncology trialsLynn A Jansen, Paul S Appelbaum, William M P Klein, et al.
IRB|February 15, 2011
Consent for future genetic research: the NHANES experience in 2007-2008Geraldine M McQuillan, Kathryn S Porter
IRB|July 2, 2010
The process is the product: a new model for multisite IRB review of data-only studiesSarah M Greene, Jeffrey Braff, Andrew Nelson, et al.
Pageof 78